Next-generation sequencing informatics market seen reaching $22.14 billion by 2030

The next-generation sequencing informatics market is projected to grow from $11.96 billion in 2026 to $22.14 billion by 2030, driven by personalized medicine, cloud-based genomic platforms and AI tools. North America leads the market now, while Asia-Pacific is expected to grow fastest through the forecast period.

Why it matters: - Next-generation sequencing informatics is becoming core infrastructure for genomics research, diagnostics and precision medicine. - The market’s projected rise signals growing demand for software and analytics that can turn large DNA and RNA datasets into clinical and research decisions. - Personalized medicine depends on this type of analysis to identify genetic variation, support targeted therapies and improve patient outcomes.

What happened: - The Business Research Company published a market outlook for next-generation sequencing informatics on August 19, 2026. - The report says the market will grow from $11.96 billion in 2026 to $22.14 billion by 2030. - The forecast implies a 16.6% compound annual growth rate over the period. - The company also said the market was valued at $10.23 billion in 2025. - The report includes a free sample and a full version available online: Download the sample report and View the full report.

The details: - Next-generation sequencing informatics uses computational tools and algorithms to analyze DNA and RNA sequencing data generated by NGS systems. - The technology helps detect genetic variations, mutations and expression patterns. - The report says historical growth was driven by precision diagnostics, high-throughput sequencing advances, expanding genomic research, personalized medicine awareness and better bioinformatics capabilities. - Future growth is expected to come from software improvements, wider use of cloud-based genomic platforms, more biotech-pharma partnerships, higher rates of genetic disorders and greater use of artificial intelligence and machine learning in genomic analysis. - The report highlights AI-powered data interpretation, cloud sequencing solutions, personalized medicine applications, sequencing automation and Internet of Things use in genomic studies as key trends. - North America held the largest market share in 2025. - Asia-Pacific is expected to be the fastest-growing region through 2030. - The report covers Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, the Middle East and Africa.

Between the lines: - The forecast suggests genomics is moving from a specialized research function to a broader data-heavy healthcare workflow. - Cloud and AI adoption point to a market that is shifting from raw sequencing capacity toward interpretation, automation and scale. - The cited rise in FDA approvals for personalized medicines, from 12 in 2022 to 26 in 2023, shows the treatment model is gaining regulatory traction, which can lift demand for sequencing analytics.

What's next: - Market growth will likely track adoption of AI-enabled analysis tools and cloud platforms across clinical and research settings. - Biotech and pharmaceutical partnerships may accelerate as companies push more targeted therapies into development. - Regional momentum should remain strongest in North America, with faster expansion expected in Asia-Pacific.